Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- Check2 days agoChange DetectedThe page has been updated to reflect new contact information for the Principal Investigator, Elizabeth A. Raetz, and the addition of the HHS Vulnerability Disclosure. Additionally, the last update date has changed to July 28, 2025, and the revision number has been updated to v2.16.8.SummaryDifference1%
- Check9 days agoChange DetectedThe webpage has updated its contact information and added new recruitment details, including new principal investigators and their contact numbers, while removing outdated contacts.SummaryDifference0.7%
- Check16 days agoChange DetectedThe web page has updated its contact information, replacing the previous principal investigator Joel A. Kaplan with Stephanie M. Villeneuve, and has introduced a service alert regarding planned maintenance starting July 25th.SummaryDifference1.0%
- Check23 days agoChange DetectedThe webpage has added new contact information for multiple principal investigators and updated the last posted date, while removing outdated information regarding the modernization of ClinicalTrials.gov data and previous update dates.SummaryDifference1%
- Check30 days agoChange DetectedThe webpage has updated its contact information for multiple principal investigators and added new recruiting dates, while removing outdated dates and a status of 'Suspended'.SummaryDifference0.8%
- Check37 days agoChange DetectedThe modernization of the ClinicalTrials.gov data ingest has been updated to July 2025, and several principal investigators and their contact information have been removed from the page.SummaryDifference4%
Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.